To better understand and predict the nature for potential toxicity in the clinic, ImmTAC-gp100-dependent activation of redirected T cells was assessed by measuring IFNγ-release in the presence of melanocytes derived from gp100-positive, HLA-A*02-positive donors, alongside a reference melanoma cell line (Mel526) (Fig 4). Here, PMEL is linked to melanoma.